Experience

Ascend Vision Partners

• United States
• Medical Practices
• 1 - 100 Employee

• Chief Executive Officer

  • May 2023 - Present

  Ascend Vision Partners supports premier ophthalmologists and optometrists who deliver exceptional eye care to patients. We provide business solutions for eye care professionals so they can focus on patient care. We offer custom business solutions for each of our partners so that your practice retains its authenticity and autonomy to meet the unique needs of your patients. We believe that when our business acumen connects with your clinical expertise we can drive eye care to the next level and deliver an exceptional patient experience. Show less



Sage Infusion

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Investor | Advisor

  • Jun 2022 - Present

  Sage Infusion is a patient focused full service specialty infusion provider for patients with autoimmune disorders and chronic infusion needs. Sage specializes eliminating avoidable cost for patients and risk-bearing providers who seek to partners with a forward thinking, value-based, infusion provider. Sage Infusion is a patient focused full service specialty infusion provider for patients with autoimmune disorders and chronic infusion needs. Sage specializes eliminating avoidable cost for patients and risk-bearing providers who seek to partners with a forward thinking, value-based, infusion provider.



Wells Pharma of Houston

• Advisory Board Member | Investor

  • Jun 2020 - Present

  Wells Pharma of Houston is an emerging 503B platform focused on fully automating the manufacturing process for compounded sterile preparations. Wells Pharma of Houston is an emerging 503B platform focused on fully automating the manufacturing process for compounded sterile preparations.



MAXhealth

• United States
• Medical Practices
• 1 - 100 Employee

• Senior Vice President - Corporate Development

  • Feb 2021 - May 2023

  Corporate Development executive responsible for the inorganic growth initiatives of MAXhealth, a portfolio Company of Arsenal Capital Partners. MAXhealth is a Florida based, primary care platform, responsible for the provision of high-quality care for its patient population. Corporate Development executive responsible for the inorganic growth initiatives of MAXhealth, a portfolio Company of Arsenal Capital Partners. MAXhealth is a Florida based, primary care platform, responsible for the provision of high-quality care for its patient population.



The Oncology Institute of Hope and Innovation

• Chief Development Officer | Growth Advisory Board Member

  • Jun 2020 - Jun 2022

  Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is the largest community oncology practice on the west coast and Florida, and the nation’s leading value-based oncology services platform. TOI employs 75 physicians and mid-levels in 40 clinic locations, with over 500 total employees helping to deliver cutting edge, evidence-based cancer care to a population of over 1 million patients. TOI brings comprehensive, integrated cancer care into community settings, including Clinical Trials, Palliative Care programs, Stem Cell Transplants, Transfusions, and other care delivery models more traditionally associated with tertiary care settings. Show less


Best Value Healthcare, LLC
• United States
• Wellness and Fitness Services
• 1 - 100 Employee
• Advisor | Investor

  • Jul 2019 - Nov 2020


Optum

• United States
• Hospitals and Health Care
• 300 - 400 Employee

• Chief Executive Officer 503B | 503A

  • Aug 2018 - Jul 2019

  CEO of Optum's 503B | 503A compounded sterile preparations business - responsible for the integration of the assets into Briova Infusion Solutions following the acquisition of Avella, by OptumRx. CEO of Optum's 503B | 503A compounded sterile preparations business - responsible for the integration of the assets into Briova Infusion Solutions following the acquisition of Avella, by OptumRx.



Avella Specialty Pharmacy

• United States
• 1 - 100 Employee

• Chief Operating Officer 503B | 503A

  • May 2018 - Aug 2018

  As the Chief Operating Officer 503B | 503A for Avella, a $1.5 billion SRx platform, I am responsible for growing the revenue and profitability of the Company's 503B and 503A compounding platforms.

• Executive Vice President - Corporate Development and Strategy

  • May 2016 - May 2018

  As the Executive Vice President of Corporate Development and Strategy for Avella, a $1.5 billion SRx platform, I am responsible for accelerating Avella's growth through long-term strategic planning and market development initiatives, partnerships, investments, acquisitions and post-merger integration. In addition, I drive organizational alignment on the positioning of Avella in the changing health care marketplace and identify new market opportunities and business models to further innovation and long-term growth. Show less



QuadMed Onsite Health and Wellness

• United States
• Medical Practices

• General Manager, Corporate Development

  • Dec 2012 - Jun 2016

  QuadMed is a nationally recognized provider of employer sponsored onsite / near site direct primary care and wellness services. The model features a full continuum of high quality, patient-centered services, which are proven to decrease costs by increasing quality, accessibility and engagement. As the General Manager for QuadMed, I was responsible for accelerating QuadMed's growth through variety of initiatives including, acquisitions (Novia), investments in new technology (StatDoctors), joint ventures, and new employer relationships. Show less



Aesyntix Health

• Investor / Advisor (SCV Portfolio Company)

  • Jan 2009 - Dec 2014

  Exited December 2014 - Modernizing Medicine (https://www.modmed.com/) - Modernizing Medicine acquired by Warburg Pincus in 2017 (http://www.warburgpincus.com/investments/modernizing-medicine/) Exited December 2014 - Modernizing Medicine (https://www.modmed.com/) - Modernizing Medicine acquired by Warburg Pincus in 2017 (http://www.warburgpincus.com/investments/modernizing-medicine/)



Oncology Plus Inc

• EVP of Business Development and Strategic Market Initiatives, Board Member (SCV Portfolio Company)

  • Jan 2010 - Oct 2012

  As EVP I was responsible for all non-pharmacy operational, financial, business development and strategic activities required to drive the growth and acceptance of a unique, centralized, oncology compounding platform. As EVP I was responsible for all non-pharmacy operational, financial, business development and strategic activities required to drive the growth and acceptance of a unique, centralized, oncology compounding platform.



Oncology Therapeutics Network (OTN)

• Chief of Staff

  • Apr 2007 - Dec 2007

  $4.0 billion distributor of specialty pharmaceuticals. Sold to McKesson in 2007. $4.0 billion distributor of specialty pharmaceuticals. Sold to McKesson in 2007.



Apogem Capital

• United States
• Financial Services
• 100 - 200 Employee

• Associate

  • Jan 2006 - Apr 2007

  Madison Capital Funding LLC provides cash flow based leveraged capital products to private equity sponsors. It offers leveraged capital products, such as lead arrangement and administration for lead arranged syndicated credit, one-stop senior credit, lead arranged club, and sole lender credit facilities; term loan and revolver participation; and equity co-investment capital. Madison Capital Funding LLC provides cash flow based leveraged capital products to private equity sponsors. It offers leveraged capital products, such as lead arrangement and administration for lead arranged syndicated credit, one-stop senior credit, lead arranged club, and sole lender credit facilities; term loan and revolver participation; and equity co-investment capital.



Lazard

• United States
• Financial Services
• 700 & Above Employee

• Goldsmith Agio Helms - Mergers & Acquisitions

  • Jun 2004 - Jan 2006

  Analyst on sell-side M&A transactions for clients in a variety of industry sectors, including healthcare, industrial manufacturing, consumer products and technology companies. Analyst on sell-side M&A transactions for clients in a variety of industry sectors, including healthcare, industrial manufacturing, consumer products and technology companies.